December 30, 2022 — The Cardiovascular Research Foundation (CRF) recently announced that Alexandra Popma, MD, has joined the organization as Executive Director of the CRF Clinical Trials Center (CTC).

December 30, 2022 — Azmi Atiya, MD, an established and highly respected cardiothoracic surgeon in the San Fernando Valley, has joined the 

December 30, 2022 — NeuroLogica Corp., a subsidiary of Samsung Electronics Co. Ltd., announced the first installation of its SmartMSU with OmniTom Elite – a specialized ambulance that is equipped with a small computed tomography (CT) scanner for head imaging – in the Asia-Pacific region.

December 29, 2022 — Modern Vascular, the national leader in minimally invasive treatment for Peripheral Artery Disease (PAD), welcomes a new managing physician, Alexander Shestopalov, MD, Vascular and Interventional Radiologist to its clinic serving the greater Houston area at 

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines — such as doxorubicin, frequently used against breast cancer — kill cancer cells by damaging their DNA.

December 27, 2022 — President Joe Biden signed into law the Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act, legislation introduced by Representative Andy Barr (R-KY) last year to honor the legacy of his wife, Carol Leavell Barr, who passed away in 2020 from sudden cardiac d

December 27, 2022 — A groundbreaking new clinical trial to determine the effectiveness of a new treatment for patients with acute heart attack is now underway at Indiana University School of Medicine, with the first patient enrolling this month.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now